- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18:42 | Boston Scientific tops expectations with 53% sales growth over 2020 | ||
| 17:42 | Signifier hypes up eXcite tongue stimulation device for sleep apnea with $35M series D | ||
| 17:42 | Ex-Kiadis CBO takes the wheel at SynOx after $358M Sanofi buyout | ||
| 17:42 | Biogen's second tau bet in Alzheimer's passes early test, though odds of success remains 'low' | ||
| 16:42 | BD fortifies surgical mesh portfolio with acquisition of polymer maker Tepha | ||
| 16:42 | AbbVie hits go on $1B re-upped Calico deal as the Google life science spin-out continues I-O, neuro push | ||
| 16:42 | AstraZeneca teams up with Regeneron for obesity-busting drug pact focused on genetics | ||
| 15:42 | Merck women's health spinout Organon bags preterm labor drug ahead of phase 3 | ||
| 15:42 | Artios raises $153M to fund DNA damage repair clinical trials | ||
| 13:42 | IMIDomics emerges with $16.5M, former Takeda exec at the helm, and a precision approach to inflammatory disease | ||
| 10:42 | As it preps for Wall Street, WCG still finding time for deals as it snaps up eClinical firm VeraSci | ||
| Mo | Prothena rolls out preclinical data for anti-amyloid Alzheimer's candidate to rival Biogen's Aduhelm | ||
| Mo | Philips' CPAP recall dents second quarter connected care sales | ||
| Mo | PathAI branches into clinical lab services with acquisition of Poplar Healthcare | ||
| Mo | Denali's Hunter syndrome data fails to impress, but 'Aduhelm-lenient' FDA could still approve | ||
| Mo | To turn off disease-causing genes, Talus Bio wants to knock proteins off of DNA | ||
| Mo | Bayer's BlueRock Therapeutics adjusts leadership team with CSO promoted to CEO | ||
| Mo | From speedy review to standstill: FDA spurns Iterum's antibiotic, demands another trial | ||
| Mo | Medtronic begins European rollout of drug-coated balloon catheter to treat blocked arteries | ||
| Mo | PerkinElmer inks massive $5.25B deal for reagent producer BioLegend | ||
| Mo | Lumira Ventures raises largest investment pot to date, nabbing $220M for life sciences bets | ||
| Mo | Abbvie posts new data on drug that could replace glasses or contacts for far-sightedness | ||
| Mo | Bayer hires Ruettinger from Roche to head early cancer R&D | ||
| Mo | FDA demands for data from Incyte as it rejects PD-1 retifanlimab for approval | ||
| Fr | Passage Bio hires CMO, CFO replacements after May departures, adds chief commercial officer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
